Gary l Johnson

Gary l Johnson

University of North Carolina at Chapel Hill

H-index: 115

North America-United States

About Gary l Johnson

Gary l Johnson, With an exceptional h-index of 115 and a recent h-index of 40 (since 2020), a distinguished researcher at University of North Carolina at Chapel Hill,

His recent articles reflect a diverse array of research interests and contributions to the field:

Illuminating function of the understudied druggable kinome

Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships

Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Phase II study of trametinib alone and in combination with uprosertib in patients with metastatic triple negative breast cancer previously treated with chemotherapy: OSU 13317

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies

Quantifying the sampling error on burn counts in Monte-Carlo wildfire simulations using Poisson and Gamma distributions

Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Abstract PD4-09: PD4-09 Single cell RNA-sequencing identifies intra-tumoral cellular heterogeneity and drug-induced subpopulation shifts in Triple Negative Breast Cancer mouse …

Gary l Johnson Information

University

Position

School of Medicine

Citations(all)

56785

Citations(since 2020)

8242

Cited By

56978

hIndex(all)

115

hIndex(since 2020)

40

i10Index(all)

365

i10Index(since 2020)

155

Email

University Profile Page

University of North Carolina at Chapel Hill

Google Scholar

View Google Scholar Profile

Top articles of Gary l Johnson

Title

Journal

Author(s)

Publication Date

Illuminating function of the understudied druggable kinome

Shawn M Gomez

David H Drewry

Timothy M Willson

Michael B Major

Reid R Townsend

...

2024/1/11

Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships

European Journal of Medicinal Chemistry

Christopher RM Asquith

Michael P East

Tuomo Laitinen

Carla Alamillo-Ferrer

Erkka Hartikainen

...

2024/4/2

Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Clinical Cancer Research

Alyssa C Flint

Dana K Mitchell

Steven P Angus

Abbi E Smith

Waylan Bessler

...

2024/5/1

Phase II study of trametinib alone and in combination with uprosertib in patients with metastatic triple negative breast cancer previously treated with chemotherapy: OSU 13317

Cancer Research

Vishnu Prasath

Hinda Boutrid

Ewa Mrozek

Maryam Lustberg

Robert Weslowski

...

2024/3/22

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies

Chinmaya U Joisa

Kevin A Chen

Samantha Beville

Timothy Stuhlmiller

Matthew E Berginski

...

2023

Quantifying the sampling error on burn counts in Monte-Carlo wildfire simulations using Poisson and Gamma distributions

Valentin Waeselynck

Gary Johnson

David Schmidt

Max A Moritz

David Saah

2023/9/28

Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma

Clinical Cancer Research

Alyssa C Flint

Dana K Mitchell

Steven P Angus

Abbi E Smith

Waylan Bessler

...

2023/9/1

Abstract PD4-09: PD4-09 Single cell RNA-sequencing identifies intra-tumoral cellular heterogeneity and drug-induced subpopulation shifts in Triple Negative Breast Cancer mouse …

Cancer Research

Cherise R Glodowski

Kevin R Mott

Denis Okumu

Michael P East

Timothy C Elston

...

2023/3/1

Small-molecule inhibition of the archetypal UbiB protein COQ8

Nature chemical biology

Nathan H Murray

Christopher RM Asquith

Zixiang Fang

Michael P East

Naomi Ptak

...

2023/2

Glioblastoma growth is suppressed dual inhibition of EGFR and CDK6 kinases

Cancer Research

Erin Smithberger

Abigail K Shelton

Ryan E Bash

Madison K Butler

Alex R Flores

...

2022/6/15

Abstract P3-15-01: Patients and Researchers Together (PART); a patient-centered tumor tissue collection PARTnership between patients and researchers to increase tissue …

Cancer Research

Patricia A Spears

Vernal Branch

Jennifer A Potter

Missy Van Lokeren

Nasrin H Babadi

...

2022/2/15

Abstract PR011: Proteomic profiling reveals subtype specific kinase expression in pancreatic cancer

Cancer Research

Yi Xu

Ashley B Morrison

Silvia G Herrera

Michael P East

Gary L Johnson

...

2022/11/15

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies

Antiviral Research

Marwah Karim

Sirle Saul

Luca Ghita

Malaya Kumar Sahoo

Chengjin Ye

...

2022/8/1

Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition

Michael P East

Gary L Johnson

2022/2/1

Identification of 4‐Anilinoquin (az) oline as a Cell‐Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype

ChemMedChem

Christopher RM Asquith

Louisa Temme

Michael P East

Tuomo Laitinen

Julie Pickett

...

2022/6/20

Acquired resistance to targeted inhibitors in EGFR-driven glioblastoma: Identification of dual kinase targets

Cancer Research

Abigail K Shelton

Erin Smithberger

Madison Butler

Allie Stamper

Ryan E Bash

...

2022/6/15

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

NPJ Breast cancer

Steven P Angus

Timothy J Stuhlmiller

Gaurav Mehta

Samantha M Bevill

Daniel R Goulet

...

2021/5/12

New strategies for targeting kinase networks in cancer

Ali E Yesilkanal

Gary L Johnson

Alexandre F Ramos

Marsha Rich Rosner

2021/10/1

Limited inhibition of multiple nodes in a driver network blocks metastasis

Elife

Ali Ekrem Yesilkanal

Dongbo Yang

Andrea Valdespino

Payal Tiwari

Alan U Sabino

...

2021/5/11

Synthesis and evaluation of novel 1, 2, 6-thiadiazinone kinase inhibitors as potent inhibitors of solid tumors

Molecules

Andreas S Kalogirou

Michael P East

Tuomo Laitinen

Chad D Torrice

Kaitlyn A Maffuid

...

2021/9/29

See List of Professors in Gary l Johnson University(University of North Carolina at Chapel Hill)